Applications are now being solicited for 2003 research grants and must be submitted by July 31. The one-time research grants range from $25,000 to $150,000 and are intended to further the development of inventive treatments for HIV/AIDS, including:
For detailed information about the GSK Drug Discovery and Development Research Grant Program, as well as an application, please call 1-888-527-6935 or visit www.dddresearchgrant.com.
"It has been gratifying to fund such innovative research and to recognize researchers - here and internationally - of this caliber," said Doug Manion, M.D., vice president of clinical development for GSK. "We've been very pleased with the diversity of the projects submitted, which have ranged from research on protein recognition to the molecular virology of HIV integration, and believe the grants provide us with a way to demonstrate our commitment to scientific research investigating the mysteries of HIV and AIDS."
Since the inception of the Drug Discovery and Development Research Grant Program in 2001, GSK has honored nine researchers for their groundbreaking work toward new pharmaceutical strategies to combat the HIV virus.
The research grant carries no obligation to the recipient's organization for licensure, patenting or transfer of confidential information, although GSK may discuss the possibility of future collaboration with some applicants.
An Expert Review Board composed of acknowledged leaders in the field of HIV/AIDS will independently judge and c
Contact: Elaine Salewske
Public Communications Inc.